Market Cap 1.92B
Revenue (ttm) 0.00
Net Income (ttm) -133.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,734,221
Avg Vol 1,532,192
Day's Range N/A - N/A
Shares Out 95.21M
Stochastic %K 25%
Beta 0.32
Analysts Strong Sell
Price Target $47.44

Latest News on EWTX

Analysts Think There's Still Time To Get In On Edgewise

Sep 30, 2024, 12:12 PM EDT - 6 months ago

Analysts Think There's Still Time To Get In On Edgewise


Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge

Sep 25, 2024, 11:50 AM EDT - 6 months ago

Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge


Wedbush's Laura Chico talks biotech investing in 2024

Dec 26, 2023, 5:21 PM EST - 1 year ago

Wedbush's Laura Chico talks biotech investing in 2024

IBB NBIX VRDN XBI